Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Lucid Diagnostics Licenses Barrett's Esophagus Biomarker Tech from CWRU

Lucid Diagnostics Licenses Barrett's Esophagus Biomarker Tech from CWRU

May 14, 2018
|
staff reporter

NEW YORK (GenomeWeb) – PavMed announced today that it has completed a definitive licensing agreement with Case Western Reserve University to develop and commercialize CWRU's EsoCheck technology.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
14
Featured Webinar

Development of a Metagenomics-based Pathogen-Detection Assay for SARS-CoV-2 Research

This webinar will describe a rapid metagenomics assay under development for human pathogens, including the SARS-CoV-2 coronavirus.

Jul
15
Featured Webinar

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

Jul
23
Featured Webinar

Clinical Utility of Liquid Biopsy for the Detection of T790M to Guide Lung Cancer Treatment Strategy

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.

What's Popular?

In Molecular Diagnostics

  1. Demand for SARS-CoV-2 Diagnostic Tests Drives Sharp Increase in 360Dx Index for First Half of 2020

  2. Accelerate, Invitae Lead Gainers as 360Dx Index Ticks Up in June

  3. Yale, NBA Validating RNA Extraction-Free Saliva Test for Coronavirus

    Premium

  4. FDA Grants EUAs for PCR Coronavirus Tests, Nasal Swab Self-Collection Kit

  5. Sherlock Biosciences, Binx Health Partner to Develop CRISPR-Based POC COVID-19 Test

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.